Met Life Investment Management, LLC Corcept Therapeutics Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,658 shares of CORT stock, worth $2.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,658
Previous 46,838 0.38%
Holding current value
$2.37 Million
Previous $1.52 Million 41.88%
% of portfolio
0.01%
Previous 0.01%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$29.51 - $46.26 $5,311 - $8,326
-180 Reduced 0.38%
46,658 $2.16 Million
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $100,278 - $155,677
4,515 Added 10.67%
46,838 $1.52 Million
Q1 2024

May 14, 2024
BUY
$21.1 - $27.46 $893,015 - $1.16 Million
42,323 New
42,323 $1.07 Million
Q3 2023

May 09, 2024
SELL
$21.97 - $33.8 $104,928 - $161,428
-4,776 Reduced 10.14%
42,323 $1.15 Million
Q2 2023

Apr 29, 2024
BUY
$21.44 - $25.15 $907,405 - $1.06 Million
42,323 New
42,323 $941,000
Q2 2023

Aug 10, 2023
SELL
$21.44 - $25.15 $102,397 - $120,116
-4,776 Reduced 10.14%
42,323 $941,000
Q1 2023

May 09, 2024
BUY
$19.2 - $24.47 $904,300 - $1.15 Million
47,099 New
47,099 $1.02 Billion
Q1 2022

May 10, 2024
BUY
$16.53 - $25.21 $778,546 - $1.19 Million
47,099 New
47,099 $1.06 Million
Q1 2022

Mar 22, 2023
BUY
$16.53 - $25.21 $219,022 - $334,032
13,250 Added 39.14%
47,099 $1.06 Million
Q1 2022

May 12, 2022
BUY
$16.53 - $25.21 $219,022 - $334,032
13,250 Added 39.14%
47,099 $1.06 Million
Q4 2021

Jun 21, 2023
SELL
$17.1 - $23.34 $226,575 - $309,255
-13,250 Reduced 28.13%
33,849 $670,000
Q3 2021

May 17, 2024
SELL
$19.68 - $22.53 $108,928 - $124,703
-5,535 Reduced 14.05%
33,849 $666,000
Q3 2021

Jun 21, 2023
SELL
$19.68 - $22.53 $260,760 - $298,522
-13,250 Reduced 28.13%
33,849 $666,000
Q3 2021

Mar 22, 2023
SELL
$19.68 - $22.53 $108,928 - $124,703
-5,535 Reduced 14.05%
33,849 $666,000
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $108,928 - $124,703
-5,535 Reduced 14.05%
33,849 $666,000
Q2 2021

Jun 21, 2023
SELL
$19.97 - $24.43 $154,068 - $188,477
-7,715 Reduced 16.38%
39,384 $866,000
Q1 2021

May 17, 2024
SELL
$23.49 - $30.56 $69,037 - $89,815
-2,939 Reduced 6.94%
39,384 $936,000
Q1 2021

Jun 26, 2023
SELL
$23.49 - $30.56 $181,225 - $235,770
-7,715 Reduced 16.38%
39,384 $937 Million
Q4 2020

May 24, 2024
SELL
$16.78 - $27.3 $68,160 - $110,892
-4,062 Reduced 9.35%
39,384 $1.03 Million
Q4 2020

Jun 22, 2023
SELL
$16.78 - $27.3 $129,457 - $210,619
-7,715 Reduced 16.38%
39,384 $1.03 Million
Q4 2020

Mar 22, 2023
SELL
$16.78 - $27.3 $68,160 - $110,892
-4,062 Reduced 9.35%
39,384 $1.03 Million
Q4 2020

Feb 16, 2021
SELL
$16.78 - $27.3 $68,160 - $110,892
-4,062 Reduced 9.35%
39,384 $1.03 Million
Q3 2020

Jun 26, 2023
SELL
$12.46 - $19.98 $45,516 - $72,986
-3,653 Reduced 7.76%
43,446 $756,000
Q2 2020

May 24, 2024
BUY
$11.0 - $18.26 $12,353 - $20,505
1,123 Added 2.65%
43,446 $731 Million
Q2 2020

Jun 26, 2023
SELL
$11.0 - $18.26 $40,183 - $66,703
-3,653 Reduced 7.76%
43,446 $730,000
Q1 2020

Jul 12, 2023
SELL
$10.11 - $14.04 $36,931 - $51,288
-3,653 Reduced 7.76%
43,446 $516,000
Q4 2019

Jul 12, 2023
SELL
$12.06 - $16.96 $44,055 - $61,954
-3,653 Reduced 7.76%
43,446 $525,000
Q3 2019

Jul 12, 2023
SELL
$10.41 - $14.66 $38,027 - $53,552
-3,653 Reduced 7.76%
43,446 $614,000
Q2 2019

Jul 12, 2023
SELL
$9.78 - $12.76 $35,726 - $46,612
-3,653 Reduced 7.76%
43,446 $484,000
Q1 2019

Jul 13, 2023
SELL
$10.03 - $15.71 $36,639 - $57,388
-3,653 Reduced 7.76%
43,446 $510,000
Q4 2018

Jul 13, 2023
SELL
$11.29 - $17.19 $41,242 - $62,795
-3,653 Reduced 7.76%
43,446 $580,000
Q4 2018

Mar 22, 2023
SELL
$11.29 - $17.19 $270,395 - $411,700
-23,950 Reduced 35.54%
43,446 $580,000
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $270,395 - $411,700
-23,950 Reduced 35.54%
43,446 $580,000
Q3 2018

Jul 13, 2023
SELL
$12.27 - $15.65 $44,822 - $57,169
-3,653 Reduced 7.76%
43,446 $609,000
Q3 2018

Mar 22, 2023
BUY
$12.27 - $15.65 $249,044 - $317,648
20,297 Added 43.09%
67,396 $944,000
Q3 2018

Nov 14, 2018
BUY
$12.27 - $15.65 $293,866 - $374,817
23,950 Added 55.13%
67,396 $945,000
Q4 2017

Feb 15, 2018
BUY
$15.77 - $20.72 $685,143 - $900,201
43,446
43,446 $785,000

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.45B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email